ImmunityBio, Inc. — Director's Dealing 2015

Oct 16, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-10-14

Reporting Person: SOON-SHIONG PATRICK (Director, Chairman and CEO, 10% Owner)
Reporting Person: MP 13 Ventures, LLC (10% Owner)
Reporting Person: Cambridge Equities, LP (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-14	Option (right to buy)	$15.295	P	2000000	Acquired	2016-03-31	Common Stock (2000000)	Indirect

Footnotes

F1: Option held by Cambridge Equities, LP ("Cambridge Equities"). MP 13 Ventures, LLC ("MP 13 Ventures") is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the option held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the option held by Cambridge Equities.